TipRanks
Annovis Bio (DE:07X)
FRANKFURT:07X
Germany Market
07X
Annovis Bio
RESEARCH TOOLSreports

Annovis Bio (07X) Income Statement

4 Followers

Annovis Bio Income Statement

Last quarter (Q2 2026), Annovis Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Annovis Bio's net income was $-14.82M. See Annovis Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Mar 23Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 29.70M$ 26.69M$ 45.03M$ 25.51M$ 14.54M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -28.85M$ -22.74M$ -56.20M$ -25.33M$ -14.50M
Operating Income
$ -29.70M$ -26.69M$ -45.03M$ -25.51M$ -14.54M
Other Income/Expenses
$ 841.06K$ 2.10M$ -11.17M$ 182.71K$ 50.09K
Pretax Income
$ -28.85M$ -24.59M$ -56.20M$ -25.33M$ -14.49M
Net Income
$ -28.85M$ -24.59M$ -56.20M$ -25.33M$ -14.49M
Per Share Metrics
Basic EPS
$ -1.40$ -2.02$ -6.23$ -3.10$ -1.90
Diluted EPS
$ -1.40$ -2.31$ -6.23$ -3.10$ -1.90
Weighted Average Shares Outstanding
 20.55M 12.18M 9.02M 8.16M 7.63M
Weighted Average Shares Outstanding (Diluted)
 20.55M 12.24M 9.02M 8.16M 7.63M
Currency in USD

Annovis Bio Earnings and Revenue History